Doctors theorized Treyson could have cerebral palsy or Angelman syndrome, a rare genetic syndrome that causes intellectual disabilities, difficulty walking and talking and seizures, many of the symptoms he possessed. Genetic testing was done. Nothing matched.
That changed in 2021 when the UW-Madison’s Center for Human Genomics and Precision Medicine began the Undiagnosed Disease Program, making it the second of its kind in the state. Part of the University’s School of Medicine and Public Health, it is often the last stop for patients who are looking for answers.